Pillstats
Rx only · Injection, Powder, Lyophilized, For Solution · Intravenous

Caspofungin Acetate

Brands: Cancidas · Caspofungin Acetate

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCJ02AX04
RxCUI (US)140108
US makers7 labelers
Packages14
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1262523795052025 Q12025 Q22025 Q32025 Q42026 Q1
170
Rx · 2026 Q1
457
Units dispensed
-61%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Fosun Pharma USA Incunknown2SUPPLYING
Fresenius Kabi USA, LLCunknown2SUPPLYING
Sandoz Incunknown2SUPPLYING
Merck Sharp & Dohme LLC.unknown2SUPPLYING
Sagent Pharmaceuticalsunknown2SUPPLYING
Gland Pharma Limitedunknown2SUPPLYING
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltdunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jun 30, 2026
    RESOLVEDShortage resolved: Caspofungin Acetate Injection (Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.))

    Caspofungin Acetate Injection — reported in shortage by Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.). Therapeutic category: Anti-Infective.

  • Jun 30, 2026
    SHORTAGEDrug shortage: Caspofungin Acetate Injection (Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.))

    Caspofungin Acetate Injection — reported in shortage by Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.). Therapeutic category: Anti-Infective.

  • Jan 12, 2026
    RESOLVEDShortage resolved: Caspofungin Acetate Injection (Fresenius Kabi USA, LLC)

    Caspofungin Acetate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Anti-Infective.

  • Jan 12, 2026
    SHORTAGEDrug shortage: Caspofungin Acetate Injection (Fresenius Kabi USA, LLC)

    Caspofungin Acetate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Anti-Infective.